Health technology assessment for gene therapies in haemophilia-Reference-Cited by-同舟云学术

Health technology assessment for gene therapies in haemophilia

Published:2022-01-25 Issue:S2 Volume:28 Page:19-26
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

O'Hara Jamie¹²,Neumann Peter J.³,

Affiliation:

1. HCD Economics Daresbury UK

2. University of Chester Chester UK

3. Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Centre Boston Massachusetts USA

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14413

Reference41 articles.

1. The past and future of haemophilia: diagnosis, treatments, and its complications

2. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment

3. WFH Guidelines for the Management of Hemophilia, 3rd edition

4. Management of Haemophilia in Developing Countries: Challenges and Options

5. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the coreHEM mental health patient‐reported outcome measure – A novel mental health outlook measure for people with haemophilia;Haemophilia;2024-09-05

2. Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands;Journal of Market Access & Health Policy;2024-07-30

3. Health utilities in adults with hemophilia A: A retrospective cohort study;Haemophilia;2024-03-20

4. Genetic variant detection in a South African haemophilia B population;Haemophilia;2024-03-10

5. Model‐Informed Approaches and Innovative Clinical Trial Design for Adeno‐Associated Viral Vector‐Based Gene Therapy Product Development: A White Paper;Clinical Pharmacology & Therapeutics;2023-06-29